Incidence and management of acute endophthalmitis after intravitreal bevacizumab (Avastin) injection. [electronic resource]
Producer: 20110325Description: 2187-93 p. digitalISSN:- 1476-5454
- Acute Disease
- Aged
- Aged, 80 and over
- Angiogenesis Inhibitors -- administration & dosage
- Anti-Bacterial Agents -- therapeutic use
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Humanized
- Bevacizumab
- Endophthalmitis -- epidemiology
- Female
- Follow-Up Studies
- Humans
- Incidence
- Intravitreal Injections -- adverse effects
- Male
- Middle Aged
- Retinal Degeneration -- drug therapy
- Retrospective Studies
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.